DR Horton Stock

Equities

DHI

US23331A1097

Homebuilding

Real-time Estimate Cboe BZX 12:41:01 2024-05-24 EDT 5-day change 1st Jan Change
144.4 USD +1.11% Intraday chart for DR Horton -4.58% -4.88%
Sales 2024 * 36.92B 50.41B Sales 2025 * 39.41B 53.8B Capitalization 47.03B 64.22B
Net income 2024 * 4.72B 6.44B Net income 2025 * 5B 6.83B EV / Sales 2024 * 1.31 x
Net Debt 2024 * 1.36B 1.86B Net Debt 2025 * 1.02B 1.39B EV / Sales 2025 * 1.22 x
P/E ratio 2024 *
10 x
P/E ratio 2025 *
9.19 x
Employees 13,450
Yield 2024 *
0.84%
Yield 2025 *
0.9%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.11%
1 week-4.58%
Current month+1.46%
1 month-1.06%
3 months-0.89%
6 months+13.41%
Current year-4.88%
More quotes
1 week
142.29
Extreme 142.29
151.93
1 month
140.00
Extreme 140
157.73
Current year
138.83
Extreme 138.83
165.75
1 year
100.08
Extreme 100.08
165.75
3 years
59.25
Extreme 59.25
165.75
5 years
25.51
Extreme 25.51
165.75
10 years
19.29
Extreme 19.29
165.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 98-12-31
Chairman 68 87-12-31
Director of Finance/CFO 58 97-12-31
Members of the board TitleAgeSince
Director of Finance/CFO 58 97-12-31
Director/Board Member 78 14-01-22
Director/Board Member 73 21-04-19
More insiders
Date Price Change Volume
24-05-24 144.6 +1.22% 337 005
24-05-23 142.8 -1.22% 1,906,847
24-05-22 144.6 -3.21% 3,094,421
24-05-21 149.4 -0.27% 1,622,311
24-05-20 149.8 -1.13% 1,390,978

Delayed Quote Nyse, May 24, 2024 at 12:25 pm

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
142.8 USD
Average target price
169.8 USD
Spread / Average Target
+18.89%
Consensus